Aquestive Therapeutics Competitors and Similar CompaniesClear all
Aquestive Therapeutics's competitors and similar companies include InsightRX, Alentis Therapeutics, Karyopharm Therapeutics and EyePoint Pharmaceuticals.
 Aquestive Therapeutics Aquestive Therapeutics is a pharmaceutical company that is engaged in drug development using PharmFilm technology. |  InsightRX InsightRX is a company that specializes in precision medicine and clinical analytics designed to individualize treatment for the healthcare and biopharmaceutical sectors. |  Alentis Therapeutics Alentis Therapeutics is a company that discovers and develops medications to treat liver diseases. |  Karyopharm Therapeutics Karyopharm Therapeutics is a commercial-stage pharmaceutical company that pioneers in cancer therapies. |  EyePoint Pharmaceuticals EyePoint Pharmaceuticals (formerly pSivida) is a pharmaceutical company focused on the development of innovative miniaturized, sustained-release drug delivery products and technologies to treat serious, debilitating diseases of the eye that can lead to blindness. | |
Founding Date | Founding Date 2004 | Founding Date 2015 | Founding Date 1993 | Founding Date 2008 | Founding Date 1987 |
Type | Type Public | Type Private | Type Private | Type Public | Type Public |
Tags | |||||
Locations | Locations Warren, US HQ | Locations San Francisco, US HQ | Locations Basel, CH HQ | Locations Newton, US HQ Givatayim, IL | Locations Watertown, US HQ |
Employees | Employees 13017% decrease | Employees 274% increase | Employees N/A | Employees 22818% decrease | Employees 8453% increase |
Valuation ($) | Valuation ($) 515.4 m | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 111.7 m | Valuation ($) 617.6 m |
Financial | |||||
Revenue (est.) | Revenue (est.) $44.5m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) $146.1m (FY, 2025) | Revenue (est.) $31.4m (FY, 2025) |
Cost of goods | Cost of goods $18.6m (FY, 2025) | Cost of goods N/A | Cost of goods N/A | Cost of goods $5.9m (FY, 2025) | Cost of goods N/A |
Gross profit | Gross profit $26m (FY, 2025) | Gross profit N/A | Gross profit N/A | Gross profit $140.1m (FY, 2025) | Gross profit N/A |
Net income | Net income ($83.8m) (FY, 2025) | Net income N/A | Net income N/A | Net income ($196m) (FY, 2025) | Net income ($232m) (FY, 2025) |
Operating ⚠ | |||||
Patents Issued | Patents Issued 200 (Q1, 2018) | Patents Issued N/A | Patents Issued N/A | Patents Issued 10 (FY, 2015) | Patents Issued N/A |
Funding | |||||
Latest funding round | Latest funding round N/A | Latest funding round $ 10m (over 6 years ago) | Latest funding round $ 67m (almost 5 years ago) | Latest funding round N/A | Latest funding round N/A |
Total funding raised | Total funding raised N/A | Total funding raised $ 12.8m | Total funding raised $ 95.3m | Total funding raised $ 248.7m | Total funding raised $ 40m |
For sources of this data, please see the company profile
View Company Profiles
InsightRX
HQ
San Francisco, US
Employees
27↑ 4% increase
InsightRX is a company that specializes in precision medicine and clinical analytics designed to individualize treatment for the healthcare and biopharmaceutical sectors.
View companyAlentis Therapeutics
HQ
Basel, CH
Alentis Therapeutics is a company that discovers and develops medications to treat liver diseases.
View companyKaryopharm Therapeutics
HQ
Newton, US
Employees
228↓ 18% decrease
Karyopharm Therapeutics is a commercial-stage pharmaceutical company that pioneers in cancer therapies.
View companyEyePoint Pharmaceuticals
HQ
Watertown, US
Employees
84
EyePoint Pharmaceuticals (formerly pSivida) is a pharmaceutical company focused on the development of innovative miniaturized, sustained-release drug delivery products and technologies to treat serious, debilitating diseases of the eye that can lead to blindness.
View company